Alterity Therapeutics Ltd. (AU:ATH) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Alterity Therapeutics Ltd., a biotech firm focused on neurodegenerative disease treatments, is switching its shareholder registry service to Automic Pty Ltd starting 7 October 2024. Shareholders will have access to Automic’s online portal for efficient management of their holdings. The new service aims to provide an improved interface for shareholders to update personal details, view account balances, and transaction history.
For further insights into AU:ATH stock, check out TipRanks’ Stock Analysis page.